File Download

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

박태주

Park, Tae Joo
Morphogenesis Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

A Recombinant Secondary Antibody Mimic as a Target-specific Signal Amplifier and an Antibody Immobilizer in Immunoassays

Author(s)
Min, JunseonSong, Eun KyungKim, HansolKim, Kyoung TaekPark, Tae JooKang, Sebyung
Issued Date
2016-04
DOI
10.1038/srep24159
URI
https://scholarworks.unist.ac.kr/handle/201301/19079
Fulltext
http://www.nature.com/articles/srep24159
Citation
SCIENTIFIC REPORTS, v.6, pp.24159
Abstract
We construct a novel recombinant secondary antibody mimic, GST-ABD, which can bind to the Fc regions of target-bound primary antibodies and acquire multiple HRPs simultaneously. We produce it in tenth of mg quantities with a bacterial overexpression system and simple purification procedures, significantly reducing the manufacturing cost and time without the use of animals. GST-ABD is effectively conjugated with 3 HRPs per molecule on an average and selectively bind to the Fc region of primary antibodies derived from three different species (mouse, rabbit, and rat). HRP-conjugated GST-ABD (HRP-GST-ABD) is successfully used as an alternative to secondary antibodies to amplify target-specific signals in both ELISA and immunohistochemistry regardless of the target molecules and origin of primary antibodies used. GST-ABD also successfully serves as an anchoring adaptor on the surface of GSH-coated plates for immobilizing antigen-capturing antibodies in an orientation-controlled manner for sandwich-type indirect ELISA through simple molecular recognition without any complicated chemical modification.
Publisher
NATURE PUBLISHING GROUP
ISSN
2045-2322
Keyword
CATALYZED REPORTER DEPOSITIONPROTEIN CAGEEP-CAMTHERAPYCANCERDOMAINAMPLIFICATIONNANOPLATFORMEXPRESSIONASSAY

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.